• SENSEX 76,059.77
    -331.62 (--0.43%)
  • BANKNIFTY 56,693.50
    101.50 (+0.18%)
  • HCL Technologies
    1,275.50 1,770.00(%)
  • Shadowfax Technologies
    203.85 98.60(%)
  • Infosys
    1,014.15 984.00(%)
  • Bluestone Jewel
    793.45 872.60(%)
  • Bajaj Finance
    1,002.00 788.40(%)
  • HDFC Bank
    737.20 726.75(%)
  • Caliber Mining
    538.15 538.15(%)
  • E2E Networks
    516.95 516.95(%)
  • Coforge
    1,488.00 1,988.90(%)
  • ICICI Pru Life
    495.55 459.60(%)
  • SBI
    1,018.00 1,234.80(%)
  • AU Small Finance
    1,015.00 1,090.40(%)
  • SRF
    2,697.50 3,257.95(%)
  • Shriram Finance
    992.75 566.40(%)
  • Maruti Suzuki
    13,498.95 17,371.60(%)
  • B H E L
    418.00 446.75(%)
  • CG Power & Ind
    839.25 525.50(%)
  • Interglobe Aviat
    4,886.70 3,894.80(%)
  • Power Grid Corpn
    285.65 250.05(%)
  • Five-Star Bus.Fi
    537.45 733.70(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Parnax Lab Ltd Pharmaceuticals - Indian - Formulations

  • Indian Private
  • BSE Code : 2018.0
  • ISIN : INE383L01019
140.05 -2 (-1.23%)
  • As on 24 Jul 2026 (EOD)

  • Today’s Low

    137.05

  • Today’s High

    141.50

  • Open

    141.00

  • Perv Close

    141.80

  • 52W Low

    99.20

  • 52W High

    182.00

Key Indicators

  • P/E(TTM)

    175.06

  • Mar.Cap (₹Cr.)

    160.86

  • Div & Yield %

    0.00

  • Book Value(₹)

    20.39

  • Debt-Equity Ratio

    -1.23

  • AGM Date

    24-Jul-2026

  • EPS

    0.80

  • P/E Ratio

    175.06

Financials Ratios

  • Debt-Equity Ratio

    1.01

  • Mar.Cap (₹Cr.)

    160.86

  • RONW (%)

    14.39

  • ROCE (%)

    12.87

Score Board

  • Equity (₹ in Cr.)

    11.49

  • BV (₹)

    20.40

  • Sales( ₹ in Cr.)

    6.63

  • NP (in Cr.)

    0.92

  • NP Var(%)

    -34.0

  • Div%

    0.0

  • CPS (₹)

    0.90

  • EPS (₹)

    0.80

  • Traded Value (₹ in Lakhs)

    160.86

  • 52 Week High

    182.00

  • 52 Week Low

    99.20

  • Price BSE

    140.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    160.86

  • P/C Ratio

    162.90

  • P/E Ratio

    174.30

  • Price Vs.BV

    0.80

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar
INCOME :            
Sales Turnover 7.02 7.44 7.47 7.15 2.37 7.68
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 7.02 7.44 7.47 7.15 2.37 7.68
Other Income 0.71 0.54 0.37 0.16 0.07 0.42
Stock Adjustments -0.13 0.25 0.00 0.00 0.00 0.00
Total Income 7.60 8.23 7.84 7.31 2.44 8.10
EXPENDITURE :            
Raw Materials 2.88 3.27 3.48 3.40 1.46 4.31
Power and Fuel Cost 0.02 0.02 0.02 0.11 0.14 0.15
Employee Cost 0.90 0.74 0.55 0.52 0.45 0.51
Other Manufacturing Expenses 1.08 1.01 1.12 1.08 0.30 0.61
Selling and Administration Expenses 0.77 0.55 0.59 0.47 0.35 0.58
Miscellaneous Expenses 0.00 0.01 0.15 0.20 0.12 0.97
Employee Benefit Expenses 0.90 0.74 0.55 0.52 0.45 0.51
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 5.65 5.59 5.90 5.78 2.82 7.14
Operating Profit 1.94 2.65 1.94 1.53 -0.38 0.95
Interest 0.02 0.14 0.25 0.71 0.83 1.38
Gross Profit 1.92 2.51 1.69 0.82 -1.21 -0.43
Depreciation 0.06 0.06 0.07 0.04 0.04 0.04
Profit Before Tax 1.86 2.45 1.62 0.78 -1.25 -0.47
Current Tax 0.00 0.00 0.00 0.00 0.13 0.00
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.46 0.62 0.42 0.24 -0.25 1.53
Reported Net Profit 1.39 1.82 1.20 0.54 -1.13 -2.00
Extraordinary Items 0.00 0.00 0.00 0.00 0.00 0.01
Adjusted Net Profit 1.39 1.82 1.20 0.54 -1.13 -2.01
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward -6.66 -8.49 -9.69 -10.23 -9.10 -7.10
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down -5.27 -6.66 -8.49 -9.69 -10.23 -9.10
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 1.21 1.59 1.05 0.55 -1.33 -2.36
Earnings Per Share(Adj)-Unit Curr 1.21 1.59 1.05 0.55 -1.33 -2.36
Book Value 19.63 18.42 16.85 11.14 5.54 6.85
Book Value(Adj)-Unit Curr 19.63 18.42 16.85 11.14 5.54 6.85

Shareholding Pattern

  • Promoter Group

    72.30%

  • Public Share Holding

    27.70%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 8,303,766 72.30 8,303,766 7
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 8,303,766 72.30 8,303,766 7
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 0 0.00 0 0
2] Non Institution
Bodies Corporate 280,138 2.44 276,988 22
Clearing Members 4,201 0.04 4,201 6
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 106,303 0.93 106,303 70
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 153,928 1.34 153,928 96
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 1,229,535 10.71 1,229,535 26
Individuals holding nominal share capital up to Rs. 1 lakh 1,378,301 12.00 1,337,501 3,340
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 26,000 0.23 26,000 2
Sub Total 3,181,850 27.70 3,137,900 3,565
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 11,485,616 100.00 11,441,666 3,572

Company Background

Parnax Lab LtdPharmaceuticals - Indian - Formulations

  • Parnax Lab Ltd
  • BSE Code : 2018.0
  • ISIN : INE383L01019

  • Incorporation Year

    1982

  • Registered Office

    Gala 114 Bldg No 8
    Jogani Ind Complex Chunabhatti, Mumbai,
    Maharashtra-400022

  • Telephone

    91-022-6825 2525

  • FAX

    91-022-2405 7728

  • Chairman

  • Managing Director

  • Company Secretary

    Preet Kukreja

  • Auditor

    C N Patel & Co

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Parnax Lab Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Parnax Lab 140.05 7.73 7.02 181.88 6.72
Abbott India 28,003.45 7,217.19 6,929.05 38.34 43.78
Astrazeneca Phar 8,000.10 2,304.07 2,275.58 106.65 27.86
P & G Health Ltd 6,723.60 944.52 934.17 34.14 71.75
Glaxosmi. Pharma 2,513.25 3,932.76 3,790.20 42.08 58.17
Cipla 1,410.90 20,102.60 18,979.95 37.08 13.88
Amrutanjan Healt 510.50 469.50 451.82 25.49 21.89
Bliss GVS Pharma 463.55 773.53 729.81 50.77 12.51
Fermenta Biotec. 432.60 474.15 450.25 19.81 18.77
Guj. Themis Bio. 360.50 152.47 150.80 84.23 27.21
Ambalal Sarabhai 32.45 19.52 3.94 22.69 6.77